Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Insider Buying This Major Airline Stock, Here's 3 Stocks Insiders Are Buying

Published 18/07/2022, 13:37
Updated 18/07/2022, 14:10
© Reuters.  Insider Buying This Major Airline Stock, Here's 3 Stocks Insiders Are Buying

Although US stocks closed higher on Friday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

Gossamer Bio

  • The Trade: Gossamer Bio, Inc. (NASDAQ: GOSS) President and CEO Faheem Hasnain acquired a total of 138,696 shares at an average price of $7.21. To acquire these shares, it cost around $1 million.
  • What’s Happening: Gossamer Bio recently announced $120 million in private placement financing.
  • What Gossamer Bio Does: Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology.
DAL
  • The Trade: Delta Air Lines, Inc. (NYSE: DAL) Director David S Taylor acquired a total of 10,000 shares at an average price of $29.31. To acquire these shares, it cost around $293.1 thousand.
  • What’s Happening: Delta Air Lines announced order for 100 737-10 aircraft with option for 30 more.
  • What Delta Air Lines Does: Atlanta-based Delta Air Lines is one of the world's largest airlines, with a network of over 300 destinations in more than 50 countries.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Also check this: Bitcoin Breaches This Major Level, Here's Other Crypto Movers That Should Be On Your Radar

Owens & Minor

  • The Trade: Owens & Minor, Inc. (NYSE: OMI) Director Robert J Henkel bought a total of 1,000 shares at an average price of $31.76. To acquire these shares, it cost around $31.76 thousand.
  • What’s Happening: The company posted upbeat earnings in May.
  • What Owens & Minor Does: Owens & Minor distributes consumable medical supplies to a variety of providers. The company operates in two segments that are Global products and Global Solutions.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.